Connect with us


Athletes call for clarity over use of CBD in sport

UK’s sports governing bodies have been urged to conduct clinical trials in the effectiveness of CBD in sport



Thousands of UK athletes are using CBD to manage pain and injuries

The athletes behind a popular UK CBD brand have called for immediate trials on the use of cannabis-derived products in sport.

The founders of Fourfive CBD have urged the UK’s sports governing bodies to conduct clinical trials into the effectiveness of CBD and medicinal cannabis in professional sport.

Two weeks ago in the US, both the NFL and NFLPA pain management committees committed to a $1 million grant to support research into the effects of cannabis, cannabinoids and non-pharmacologic treatments on pain and athletic performance in American football.

Since the World Anti-Doping Agency (WADA) sanctioned the use of CBD in sport in 2017, thousands of professional athletes have been using the supplement, with many publicly endorsing its benefits. 

Founded by professional rugby players, Dominic Day and George Kruis, Fourfive is a popular brand with both amateurs and professional sports people, with advocates including football, rugby, cricket, hockey and golf stars. 

Many are choosing CBD to manage pain and injuries, as an alternative to standard pharmacological treatments, having highlighted a culture of heavy opioid-use in professional sport. 

Fourfive CBD founders, Dominic Day and George Kruis

Despite fears about the undeclared levels of THC in some products, an FOI request submitted by Cannabis Health earlier this year found that the cannabinoid has not been linked to a single failed drugs test in UK sport.

But individual sports governing bodies, as well as Sport England, have thus far been reluctant to show any leadership or foresight on the topic. 

Day, co-founder, Fourfive, said: “We are hearing from countless customers about the benefits of CBD, not just from athletes but from anyone who leads an active lifestyle, they are telling us that CBD helps with pain management, sleep disorders and anxiety. 

“We want the UK’s sport bodies including the RFU, the FA and even Sport England to step up and commit to research which looks at the benefits of CBD and medicinal cannabis so the industry can fulfil its potential. ”

The overall market for CBD in the UK is expected to be worth £690 million by the end of 2021.

While The Food Standards Authority (FSA) has moved to provide regulation around the supply of CBD through its novel food directive, sports authorities have been reluctant and slow to provide guidance and evidence to the athletes they represent.



Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister title and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.